Visit our Filed page for categories. To browse by specific topic, see our Inside page. For a list of companies covered on this site, visit our Companies page.
Johnson & Johnson’s revenue has slumped for a second straight year, prompting its chief executive to make an extraordinary pitch to soothe investors and defend the company’s handling of 17 costly recalls.
The health care giant, hammered by the weak global economy, growing pricing pressures and recalls that have kept many popular nonprescription medicines off store shelves, reported Tuesday a 12 percent profit decline and a 5.5 percent drop in sales for the fourth quarter. Get the full story »
Johnson & Johnson recalled nearly 47 million units of over-the-counter medicines Friday, the latest in a string of quality-related product recalls.
J&J said the latest recall resulted from a thorough examination of manufacturing records that the company had undertaken in the wake of earlier recalls. J&J plans to continue reviewing practices at additional plants and signaled further recalls could result. Get the full story »
Health care giant Johnson & Johnson is announcing another product recall, this one involving some Children’s Benadryl Allergy Fastmelt Tablets and Junior Strength Motrin Caplets. Get the full story »
Johnson & Johnson is expanding a recall of over-the-counter drugs including Tylenol and Motrin IB because of a musty or moldy smell.
The McNeil Consumer Healthcare business says it is recalling 21 lots of over-the-counter drugs sold in the U.S., Puerto Rico, Fiji, Guatemala, Dominican Republic, Trinidad and Tobago and Jamaica. Get the full story »
